New cancer drug LUNA18 tested in early human trial
Disease control
Terminated
This early-phase trial tested a new drug called LUNA18, taken as a capsule, alone or with another cancer drug (cetuximab), in 128 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and se…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC